Heterogeneity in cost-effectiveness analysis of vaccination for mild and moderate Alzheimer's disease.

CONCLUSION: There were considerable heterogeneities observed in the CEA of vaccination for AD. As with the development of personalized medicine, the CEA results assessed by health decision-maker should not only be considered by population-average level but also specific sub-group levels. PMID: 31195946 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/31195946?dopt=Abstract

Source: Current Alzheimer Research - June 11, 2019 Category: Neurology Authors: Lin CH, Fann JC, Chen SL, Chen HH, Yang KC Tags: Curr Alzheimer Res Source Type: research